Evidence map›Paper›PMID 40621122›Full record

ArticleGHM open2025

The Academic Research Organization Alliance for Southeast and East Asia (ARISE) in the new era: An international trials network towards pandemic preparedness.

Phuong Mai Le, Sifa Marie Joelle Muchanga, Maria Ruriko Umano Urbiztondo, Marlinang Diarta Siburian, Katsumi Ishii, Naoki Tomotsugu, Koji Wada, Daisuke Tokita, Wataru Sugiura

Abstract readLetter
In one paragraph

Article in GHM open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Phuong Mai LeDepartment of International Trials, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Sifa Marie Joelle MuchangaDepartment of International Trials, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Maria Ruriko Umano UrbiztondoDepartment of International Trials, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Marlinang Diarta SiburianDepartment of International Trials, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Katsumi IshiiDepartment of International Trials, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Naoki TomotsuguDepartment of International Trials, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Koji WadaDepartment of International Trials, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Daisuke TokitaDepartment of International Trials, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Wataru SugiuraCenter for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Academic Research Organizations (ARO) Alliance for Southeast and East Asia (ARISE), established in 2021, is a network of academic research organizations in Southeast and East Asia. Its founding vision was focused on conducting effective, high-quality clinical research and providing timely access to new medicinal products during health crises. Through its focused efforts, ARISE has fostered regional cooperation and contributed to implementing clinical trials of medical products in its network. In response to global health challenges, the Government of Japan is establishing a new organization, the Japan Institute for Health Security, with functions encompassing infectious disease control and pandemic preparedness. As ARISE continues to fulfill its mission of addressing emerging infectious diseases, the ongoing changes in its founding organization will significantly impact its operations. With this article, we aim to highlight ARISEs achievements in its first two years and to explain how its strategy has been adapted to the new organizational structure and evolving global health landscape. ARISE strives to strengthen its network collaboration and further enhance the ability of member organizations to respond rapidly and effectively to future health emergencies.

Indexed as

ARISEAROclinical trialsinfectious diseasespandemic preparedness

Identifiers

PMID40621122
PMCPMC12226768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.